Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas du Bois

Showing results (1-10 of 262) with videos related to

Pageof 27
Sort By:
Current Opinion in Oncology|August 12, 2005
The role of surgery in ovarian cancer with special emphasis on cytoreductive surgery for recurrencePhilipp Harter, Andreas du Bois
Expert Review of Anticancer Therapy|September 19, 2018
Patient-reported outcomes in ovarian cancer: are they key factors for decision making?Felix Hilpert, Andreas Du Bois
Expert Review of Anticancer Therapy|November 1, 2016
Factors to consider and questions to ask in the management of recurrent ovarian cancer: a focus on the role of trabectedin + pegylated liposomal doxorubicinAntonio González-Martín, Andreas du Bois
Onkologie|August 8, 2013
Fertility-sparing surgery in ovarian cancer: a systematic reviewAndreas du Bois, Florian Heitz, Philipp Harter
BMC Medical Research Methodology|January 23, 2014
Mediation analysis of the relationship between institutional research activity and patient survivalJustine Rochon, Andreas du Bois, Theis Lange
Current Oncology Reports|August 25, 2012
Surgery for relapsed ovarian cancer: when should it be offered?Philipp Harter, Florian Heitz, Andreas du Bois
Future Oncology (London, England)|October 4, 2012
The changing landscape of therapeutic strategies for recurrent ovarian cancerKlaus H Baumann, Uwe Wagner, Andreas du Bois
Onkologie|December 14, 2004
Why institutions do not participate in ovarian cancer trials -- results from a survey in GermanyJalid Sehouli, Julia Kostromitskaia, Dirk Stengel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 28, 2014
The sandwich technique of diaphragmatic stripping or full-thickness resection for advanced ovarian cancer: how to keep it short and simpleChristoph Grimm, Philipp Harter, Florian Heitz, et al.
Critical Reviews in Oncology/Hematology|September 29, 2009
Pegylated liposomal doxorubicin combined with carboplatin: a rational treatment choice for advanced ovarian cancerSandro Pignata, Eric Pujade Lauraine, Andreas du Bois, et al.
Pageof 27

Showing results (1-10 of 262) with videos related to

Sort By:
Pageof 27
Current Opinion in Oncology|August 12, 2005
The role of surgery in ovarian cancer with special emphasis on cytoreductive surgery for recurrencePhilipp Harter, Andreas du Bois
Expert Review of Anticancer Therapy|September 19, 2018
Patient-reported outcomes in ovarian cancer: are they key factors for decision making?Felix Hilpert, Andreas Du Bois
Expert Review of Anticancer Therapy|November 1, 2016
Factors to consider and questions to ask in the management of recurrent ovarian cancer: a focus on the role of trabectedin + pegylated liposomal doxorubicinAntonio González-Martín, Andreas du Bois
Onkologie|August 8, 2013
Fertility-sparing surgery in ovarian cancer: a systematic reviewAndreas du Bois, Florian Heitz, Philipp Harter
BMC Medical Research Methodology|January 23, 2014
Mediation analysis of the relationship between institutional research activity and patient survivalJustine Rochon, Andreas du Bois, Theis Lange
Current Oncology Reports|August 25, 2012
Surgery for relapsed ovarian cancer: when should it be offered?Philipp Harter, Florian Heitz, Andreas du Bois
Future Oncology (London, England)|October 4, 2012
The changing landscape of therapeutic strategies for recurrent ovarian cancerKlaus H Baumann, Uwe Wagner, Andreas du Bois
Onkologie|December 14, 2004
Why institutions do not participate in ovarian cancer trials -- results from a survey in GermanyJalid Sehouli, Julia Kostromitskaia, Dirk Stengel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 28, 2014
The sandwich technique of diaphragmatic stripping or full-thickness resection for advanced ovarian cancer: how to keep it short and simpleChristoph Grimm, Philipp Harter, Florian Heitz, et al.
Critical Reviews in Oncology/Hematology|September 29, 2009
Pegylated liposomal doxorubicin combined with carboplatin: a rational treatment choice for advanced ovarian cancerSandro Pignata, Eric Pujade Lauraine, Andreas du Bois, et al.
Pageof 27